S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
FB   217.95 (-0.82%)
MSFT   165.04 (-1.01%)
GOOGL   1,466.17 (-1.25%)
AMZN   1,861.64 (-1.22%)
CGC   22.65 (-7.78%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
GE   11.71 (-0.51%)
TSLA   564.82 (-1.29%)
AMD   50.35 (-2.63%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
NFLX   353.16 (+1.02%)
PRI   122.53 (-2.41%)
BAC   33.54 (-1.70%)
DIS   140.08 (-1.49%)
GILD   63.15 (-1.24%)
S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
FB   217.95 (-0.82%)
MSFT   165.04 (-1.01%)
GOOGL   1,466.17 (-1.25%)
AMZN   1,861.64 (-1.22%)
CGC   22.65 (-7.78%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
GE   11.71 (-0.51%)
TSLA   564.82 (-1.29%)
AMD   50.35 (-2.63%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
NFLX   353.16 (+1.02%)
PRI   122.53 (-2.41%)
BAC   33.54 (-1.70%)
DIS   140.08 (-1.49%)
GILD   63.15 (-1.24%)
S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
FB   217.95 (-0.82%)
MSFT   165.04 (-1.01%)
GOOGL   1,466.17 (-1.25%)
AMZN   1,861.64 (-1.22%)
CGC   22.65 (-7.78%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
GE   11.71 (-0.51%)
TSLA   564.82 (-1.29%)
AMD   50.35 (-2.63%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
NFLX   353.16 (+1.02%)
PRI   122.53 (-2.41%)
BAC   33.54 (-1.70%)
DIS   140.08 (-1.49%)
GILD   63.15 (-1.24%)
S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
FB   217.95 (-0.82%)
MSFT   165.04 (-1.01%)
GOOGL   1,466.17 (-1.25%)
AMZN   1,861.64 (-1.22%)
CGC   22.65 (-7.78%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
GE   11.71 (-0.51%)
TSLA   564.82 (-1.29%)
AMD   50.35 (-2.63%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
NFLX   353.16 (+1.02%)
PRI   122.53 (-2.41%)
BAC   33.54 (-1.70%)
DIS   140.08 (-1.49%)
GILD   63.15 (-1.24%)
Log in

NYSE:CTST - CannTrust Stock Price, Forecast & News

C$1.06
-0.05 (-4.50 %)
(As of 01/24/2020 04:00 PM ET)
Today's Range
C$1.01
Now: C$1.06
C$1.12
50-Day Range
C$0.80
MA: C$0.96
C$1.18
52-Week Range
C$0.75
Now: C$1.06
C$10.17
Volume1.33 million shs
Average Volume2.24 million shs
Market CapitalizationC$149.98 million
P/E RatioN/A
Dividend YieldN/A
Beta3.25
CannTrust Holdings Inc produces and sells medical and recreational cannabis in Canada. It sells dried cannabis and cannabis extracts to the medical patients. CannTrust Holdings Inc was incorporated in 2015 and is headquartered in Vaughan, Canada.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone64-7872-2300

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$35.22 million
Book ValueC$1.27 per share

Profitability

Miscellaneous

Employees576
Market CapC$149.98 million
Next Earnings Date3/26/2020 (Estimated)
OptionableOptionable

Receive CTST News and Ratings via Email

Sign-up to receive the latest news and ratings for CTST and its competitors with MarketBeat's FREE daily newsletter.


CannTrust (NYSE:CTST) Frequently Asked Questions

What is CannTrust's stock symbol?

CannTrust trades on the New York Stock Exchange (NYSE) under the ticker symbol "CTST."

When is CannTrust's next earnings date?

CannTrust is scheduled to release their next quarterly earnings announcement on Thursday, March 26th 2020. View Earnings Estimates for CannTrust.

What price target have analysts set for CTST?

8 brokerages have issued twelve-month price objectives for CannTrust's shares. Their forecasts range from C$2.00 to C$7.00. On average, they expect CannTrust's stock price to reach C$4.50 in the next year. This suggests a possible upside of 324.5% from the stock's current price. View Analyst Price Targets for CannTrust.

What is the consensus analysts' recommendation for CannTrust?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CannTrust in the last year. There are currently 1 sell rating, 4 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for CannTrust.

Has CannTrust been receiving favorable news coverage?

News stories about CTST stock have trended somewhat negative this week, InfoTrie reports. InfoTrie scores the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. CannTrust earned a coverage optimism score of -1.9 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for CannTrust.

Are investors shorting CannTrust?

CannTrust saw a decline in short interest in December. As of December 13th, there was short interest totalling 12,050,000 shares, a decline of 8.2% from the November 28th total of 13,120,000 shares. Based on an average daily trading volume, of 1,970,000 shares, the days-to-cover ratio is currently 6.1 days. Currently, 10.1% of the shares of the company are sold short. View CannTrust's Current Options Chain.

Who are some of CannTrust's key competitors?

What other stocks do shareholders of CannTrust own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CannTrust investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Aphria (APHA), KushCo (KSHB), Cronos Group (CRON), Aurora Cannabis (ACB), OrganiGram (OGI), HEXO (HEXO), Nokia Oyj (NOK) and Aphria (APHA).

Who are CannTrust's key executives?

CannTrust's management team includes the folowing people:
  • Mr. Eric Paul, Co-Founder & Chairman (Age 78)
  • Mr. Brad Rogers, Pres (Age 49)
  • Mr. Ian Abramowitz, Sr. VP of Global Investments & Partnerships (Age 64)
  • Mr. Peter Ralph Aceto, Chief Exec. Officer
  • Mr. Greg Guyatt, Chief Financial Officer

How do I buy shares of CannTrust?

Shares of CTST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is CannTrust's stock price today?

One share of CTST stock can currently be purchased for approximately C$1.06.

How big of a company is CannTrust?

CannTrust has a market capitalization of C$149.98 million and generates C$35.22 million in revenue each year. The company earns C$-10,460,000.00 in net income (profit) each year or C($0.11) on an earnings per share basis. CannTrust employs 576 workers across the globe.View Additional Information About CannTrust.

What is CannTrust's official website?

The official website for CannTrust is http://www.canntrust.ca/.

How can I contact CannTrust?

CannTrust's mailing address is 3280 LANGSTAFF ROAD UNIT 1, VAUGHAN A6, L4K 4Z8. The company can be reached via phone at 64-7872-2300 or via email at [email protected]


MarketBeat Community Rating for CannTrust (NYSE CTST)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  164 (Vote Outperform)
Underperform Votes:  183 (Vote Underperform)
Total Votes:  347
MarketBeat's community ratings are surveys of what our community members think about CannTrust and other stocks. Vote "Outperform" if you believe CTST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CTST will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/24/2020 by MarketBeat.com Staff

Featured Article: What is a capital gain?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel